Myeloma Paper of the Day, July 25th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of myeloma patient preferences on clinical decision making concludes that many choose against treatments that improve PFS if they do not positively affect OS and lead to clinical, financial, and/or time toxicities.”
Title: Patient Preferences on Clinical Decision Making in Multiple Myeloma
Authors: Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Mason S. Barnes, Jorge Arturo Hurtado Martinez, Jay R. Hydren, Douglas Sborov, Amandeep Godara, Brian McClune, Christopher M. Booth, Edward R. Scheffer Cliff.
You can read the Full Article in JCO Oncology Practice.
You can find more posts featuring Robert Orlowski in OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023